Corrigendum to: Physiologically-based pharmacokinetic modeling to evaluate in vitro-to-in vivo extrapolation for intestinal P-glycoprotein inhibition.
作者信息
Yamazaki Shinji, Evers Raymond, De Zwart Loeckie
出版信息
CPT Pharmacometrics Syst Pharmacol. 2022 Oct;11(10):1394. doi: 10.1002/psp4.12860. Epub 2022 Sep 1.
Abstract
摘要
相似文献
1
Corrigendum to: Physiologically-based pharmacokinetic modeling to evaluate in vitro-to-in vivo extrapolation for intestinal P-glycoprotein inhibition.更正：基于生理的药代动力学建模以评估肠道P-糖蛋白抑制的体外到体内外推
CPT Pharmacometrics Syst Pharmacol. 2022 Oct;11(10):1394. doi: 10.1002/psp4.12860. Epub 2022 Sep 1.
2
Physiologically-based pharmacokinetic modeling to evaluate in vitro-to-in vivo extrapolation for intestinal P-glycoprotein inhibition.基于生理学的药代动力学模型评价肠道 P 糖蛋白抑制的体外向体内的推断。
CPT Pharmacometrics Syst Pharmacol. 2022 Jan;11(1):55-67. doi: 10.1002/psp4.12733. Epub 2021 Nov 6.
3
Evaluation of Age-Related Pyrethroid Pharmacokinetic Differences in Rats: Physiologically-Based Pharmacokinetic Model Development Using In Vitro Data and In Vitro to In Vivo Extrapolation.评估大鼠中与年龄相关的拟除虫菊酯药代动力学差异：使用体外数据和体外到体内外推法开发基于生理学的药代动力学模型。
Toxicol Sci. 2019 Jun 1;169(2):365-379. doi: 10.1093/toxsci/kfz042.
4
Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.半机械论生理基于药代动力学模型对临床格列本脲药代动力学和药物相互作用的研究。
Eur J Pharm Sci. 2013 Aug 16;49(5):819-28. doi: 10.1016/j.ejps.2013.06.009. Epub 2013 Jun 24.
5
Application of Physiologically Based Pharmacokinetic Modeling in Understanding Bosutinib Drug-Drug Interactions: Importance of Intestinal P-Glycoprotein.生理药代动力学模型在理解博舒替尼药物相互作用中的应用：肠 P-糖蛋白的重要性。
Drug Metab Dispos. 2018 Aug;46(8):1200-1211. doi: 10.1124/dmd.118.080424. Epub 2018 May 8.
6
In Vitro-In Vivo Extrapolation Scaling Factors for Intestinal P-glycoprotein and Breast Cancer Resistance Protein: Part II. The Impact of Cross-Laboratory Variations of Intestinal Transporter Relative Expression Factors on Predicted Drug Disposition.肠道P-糖蛋白和乳腺癌耐药蛋白的体外-体内外推比例因子：第二部分。肠道转运蛋白相对表达因子的跨实验室差异对预测药物处置的影响。
Drug Metab Dispos. 2016 Mar;44(3):476-80. doi: 10.1124/dmd.115.067777. Epub 2016 Feb 3.
7
A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolation.基于生理药代动力学模型用于跨物种外推的系统评价。
J Pharm Sci. 2015 Jan;104(1):191-206. doi: 10.1002/jps.24214. Epub 2014 Nov 12.
8
Application of an Accessible Interface for Pharmacokinetic Modeling and to Extrapolation.用于药代动力学建模和外推的可访问接口的应用。
Front Pharmacol. 2022 Apr 13;13:864742. doi: 10.3389/fphar.2022.864742. eCollection 2022.
9
Mechanistic Modeling of In Vitro Skin Permeation and Extrapolation to In Vivo for Topically Applied Metronidazole Drug Products Using a Physiologically Based Pharmacokinetic Model.使用基于生理的药代动力学模型对局部应用的甲硝唑药品进行体外皮肤渗透的机制建模及体内外推
Mol Pharm. 2022 Sep 5;19(9):3139-3152. doi: 10.1021/acs.molpharmaceut.2c00229. Epub 2022 Aug 15.
10
Biopharmaceutic Extrapolation (IVIV_E) Informed Physiologically-Based Pharmacokinetic Model of Ritonavir Norvir Tablet Absorption in Humans Under Fasted and Fed State Conditions.生物制药外推法（IVIV_E）指导下的利托那韦软胶囊在禁食和进食状态下人体吸收的基于生理的药代动力学模型。
Mol Pharm. 2020 Jul 6;17(7):2329-2344. doi: 10.1021/acs.molpharmaceut.0c00043. Epub 2020 Jun 1.
本文引用的文献
1
Physiologically-based pharmacokinetic modeling to evaluate in vitro-to-in vivo extrapolation for intestinal P-glycoprotein inhibition.基于生理学的药代动力学模型评价肠道 P 糖蛋白抑制的体外向体内的推断。
CPT Pharmacometrics Syst Pharmacol. 2022 Jan;11(1):55-67. doi: 10.1002/psp4.12733. Epub 2021 Nov 6.
Zotero 插件